交易 Bristol Myers BMY

BristolMyers實時圖表

金融工具基礎知識

Weekly Search
Weekly
Daily
日期 關閉 更改 更改(%): 開倉

BristolMyers 新聞

許景桓 2025 Jul 15, 08:10

歐洲清算銀行警告歐盟:投資遭凍結俄羅斯資產可能等同於「沒收」

許景桓 2025 Jul 15, 07:10

2026年白銀價格預測:麥格理銀行深度分析

盧昕穎 2025 Jul 15, 07:10

2025年關稅與通貨膨脹:為何物價沒有飆升?

許景桓 2025 Jul 15, 06:10

祖克柏投入數千億美元於AI數據中心,加劇人才爭奪戰

張瑋庭 2025 Jul 15, 03:10

聯準會量化緊縮與銀行準備金:華爾街的觀點

黃達傑 2025 Jul 14, 16:00

加密貨幣觀察:SOLUSD 預測、ETH 價格、XRP 新聞、狗狗幣價格

黃達傑 2025 Jul 10, 16:00

全球市場差價合約(CFD)交易:股票、外匯、商品、債券、指數及更多

黃達傑 2025 Jul 08, 16:00

替代Nvidia股票:Nvidia的競爭對手是誰?

黃達傑 2025 Jul 06, 16:00

觀察木材股票:SSD 股票、UFPI 股票、HD 股票

黃達傑 2025 Jun 30, 16:00

值得關注的能源股票:Chevron Corporation (CVX), EPD, SLB

最新新聞

顯示更多
許景桓 2025 Jul 15, 10:20

川普鼓勵烏克蘭深入打擊俄羅斯境內:戰略轉變與潛在升級

盧昕穎 2025 Jul 15, 09:20

川普的關稅威脅:歐洲力圖避免全面貿易戰

陳昊然 2025 Jul 15, 06:20

美國通膨:CPI、關稅影響與聯準會政策

張瑋庭 2025 Jul 15, 06:20

黃金價格展望:關稅、各國央行與供應動態

張瑋庭 2025 Jul 15, 02:20

比特幣突破盤整,在監管樂觀情緒中飆升至 12 萬美元以上

張瑋庭 2025 Jul 15, 01:20

凱文·哈塞特可能成為川普政府下的聯準會主席:一項分析

林芷柔 2025 Jul 15, 01:20

美歐貿易緊張升級:關稅威脅迫在眉睫

陳昊然 2025 Jul 14, 13:20

川普政府利用聯準會翻新工程,在利率爭端中逼迫鮑爾下台

聯絡方式

點差

0.29

點差(%)

0.6141 %

槓桿

1:10

隔夜利息(買入)

-0.0597 %

隔夜利息(賣出)

-0.0292 %

貨幣

USD

交易時間

市場關閉

星期二

13:31 - 19:59

星期一

13:31-19:59

星期三

13:31-19:59

星期四

13:31-19:59

星期五

13:31-19:59

分析與統計

開倉

---

上一次平倉

---

52 週高點/低點

--- – ---

市值

95363850240

流通股份

2035079936

收益日期(下一個)

2001-08-07

現金殖利率 

2025-08-01

除息日

2025-07-03

遠期年股息率

2.48

遠期年現金殖利率

0.0536

每股盈餘

2.68

了解有關此金融工具的詳細資訊

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

相關工具

資產
出售
購買
更改(%):
查看所有金融工具

最新教育文章

顯示更多
黃達傑 2025 Jul 14, 16:00

Stellar 價格 (XLM) 在 6 天內飆升 110%:如何交易 Stellar CFD?

黃達傑 2025 Jul 13, 16:00

NIO 股價及預測:關於 NIO 股票的資訊

黃達傑 2025 Jul 13, 16:00

BA 股票正在上漲:波音公司股票(BA)現在值得買入嗎?

Trustpilot